- Trials with a EudraCT protocol (28)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
28 result(s) found for: .cop.
Displaying page 1 of 2.
EudraCT Number: 2008-000069-41 | Sponsor Protocol Number: THCHOG-2008-01 | Start Date*: 2008-04-09 |
Sponsor Name:Erasmus MC | ||
Full Title: Regulation of colloid osmotic pressure during cardiopulmonary bypass in infants: prospective randomised trial | ||
Medical condition: Regulation of COP during CPB in infants | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003441-26 | Sponsor Protocol Number: Protocol_CORTICO-COP_PSJUJ | Start Date*: 2016-03-02 | |||||||||||
Sponsor Name:Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN) | |||||||||||||
Full Title: CORTICO-COP (CORTICOsteroid reduction in COPD) trial | |||||||||||||
Medical condition: 1) Whether a reduction of the dose systemic corticosteroids (SC) therapy in patients with acute exacerbation of COPD(AE-COPD) - compared with AE-COPD patients in the standard treatment- leading to ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-001198-55 | Sponsor Protocol Number: KronLungesyg_COVID_19_protokol_2 | Start Date*: 2020-04-03 | ||||||||||||||||
Sponsor Name:Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN) | ||||||||||||||||||
Full Title: Proactive Prophylaxis with Azithromycin and Hydroxychloroquine Patients Hospitalized with COVID | ||||||||||||||||||
Medical condition: This trial will investigate infection with coronavirus (COVID-19) in patients who are admitted to hospital | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2015-003399-58 | Sponsor Protocol Number: COPTRIN1 | Start Date*: 2017-01-14 | |||||||||||
Sponsor Name:COP:TRIN Region Hovedstaden (Gentofte hospital) | |||||||||||||
Full Title: Target-ABC (Targeted AntiBiotics for Chronic pulmonary disease): Can targeted antibiotic therapy improve the prognosis of Pseudomonas aeruginosa infected patients with chronic pulmonary obstructiv... | |||||||||||||
Medical condition: Respiratory tract infection Bacterial infection with Pseudomonas aeruginosa Chronic obstructive pulmonary disease (COPD) Non-cystic fibrosis bronchiectasis Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003321-99 | Sponsor Protocol Number: ANES002 | Start Date*: 2012-03-02 |
Sponsor Name:UZ Brussels | ||
Full Title: Comparison of Volulyte® versus Tetraspan® in patients undergoing cardiopulmonary bypass. | ||
Medical condition: coagulation status, colloid oncotic pressure (COP) and ion- and acid-base balance. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-005507-41 | Sponsor Protocol Number: NV18210 | Start Date*: 2007-01-28 | |||||||||||
Sponsor Name:F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: Randomized, Multicenter, Double-Blinded, Phase IV Study Evaluating the Efficacy (as measured by Sustained Virological Response) and Safety of 360 µg Induction Dosing of Pegasys in Combination with ... | |||||||||||||
Medical condition: genotype 1 chronic hepatitis C infection of high viral titer and baseline body weight greater than or equal to 85 kg | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) NL (Completed) SE (Completed) DE (Completed) BE (Completed) DK (Completed) FR (Completed) GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003430-85 | Sponsor Protocol Number: OBERAL | Start Date*: 2017-11-29 |
Sponsor Name:Helsinki University Hospital | ||
Full Title: A randomized, open, parallel design study to evaluate the effect on liver fat, adipose tissue and metabolic parameters when switching a protease inhibitor or efavirenz to once daily raltegravir in ... | ||
Medical condition: Study subjects are HIV infected patients with BMI>25kg/m2 and who have at least one metabolic syndrome component or a fatty liver disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-003174-50 | Sponsor Protocol Number: ALBUCEF | Start Date*: 2021-01-28 |
Sponsor Name:Medical University of Vienna Department of Cardiac Thoracic Vascular Anesthesia and Intensive Care Medicine | ||
Full Title: The Effect of Albumin Levels on Pharmacokinetics of Cefazolin in Adult Cardiac Surgery: A Prospective, Randomized, Open-label, Parallel-group Pharmacokinetic Study | ||
Medical condition: effect of hypoalbuminemia on pharmacokinetics of cefazolin | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2019-004871-38 | Sponsor Protocol Number: BIFAST | Start Date*: 2020-06-03 |
Sponsor Name:FUNDACION JIMENEZ DIAZ HEALTH RESEARCH INSTITUTE | ||
Full Title: Phase IV, single-center, open study to assess the benefits of the start of immediate treatment without immunovirological data (“Same Day Treatment”) compared to conventional treatment with BIC / FT... | ||
Medical condition: HIV infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003014-12 | Sponsor Protocol Number: COPERNICOS_JUJCPR | Start Date*: 2021-03-19 | |||||||||||
Sponsor Name:Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN) | |||||||||||||
Full Title: COPD - Eosinophil-guided Reduction of Inhaled COrticoSteroids (COPERnICOS) | |||||||||||||
Medical condition: Clinicaltrial on eosinophil-guided time-updated person-specific reduction of inhaled corticosteroid therapy and prophylactic azithromycin therapy in patients with severe or very severe chronic obst... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003836-35 | Sponsor Protocol Number: 2017-001-COPAF | Start Date*: 2018-08-17 | ||||||||||||||||
Sponsor Name:Population Health Research Institute | ||||||||||||||||||
Full Title: Colchicine For The Prevention Of Perioperative Atrial Fibrillation In Patients Undergoing Thoracic Surgery (COP-AF) | ||||||||||||||||||
Medical condition: Perioperative atrial fibrillation / atrial flutter after thoracic surgery | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Ongoing) BE (Completed) IT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2007-004519-67 | Sponsor Protocol Number: A10-174 | Start Date*: 2008-01-22 |
Sponsor Name:Fundació de Lluita Contra la Sida | ||
Full Title: ENSAYO CLÍNICO PROSPECTIVO, ABIERTO Y ALEATORIZADO, SOBRE LA SEGURIDAD HEPÁTICA DEL TRATAMIENTO ANTIRRETROVIRAL QUE INCLUYE KALETRA VS NEVIRAPINA EN PACIENTES COINFECTADOS VIH/VHC. ESTUDIO KANELA. | ||
Medical condition: Fibrosis hepática en pacientes co-infectados VIH-VHC | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2021-005927-19 | Sponsor Protocol Number: GESIDA11920 | Start Date*: 2022-05-17 | |||||||||||
Sponsor Name:Fundación SEIMC-GESIDA | |||||||||||||
Full Title: Phase IV, randomized, multicenter, double-blind clinical trial designed to evaluate the safety and convenience of switching from Dolutegravir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir alafe... | |||||||||||||
Medical condition: Human immunodeficiency virus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001525-21 | Sponsor Protocol Number: MANON-02 | Start Date*: 2005-01-31 | |||||||||||
Sponsor Name:ORVACS, Objectif Recherche Vaccin SIDA | |||||||||||||
Full Title: Estudio clínico controlado con placebo, aleatorizado, de fase II, para evaluar la inmunogenicidad y la toxicidad de dos patrones de inducción-refuerzo complementarios con el ALVAC-VIH vCP1452 en pa... | |||||||||||||
Medical condition: Infección por el VIH | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006730-33 | Sponsor Protocol Number: VIHIL2 | Start Date*: 2008-06-23 | |||||||||||
Sponsor Name:Hospital Universitario Virgen del Rocío | |||||||||||||
Full Title: Estudio de los mecanismos implicados en la recuperación de linfocitos CD4+ propiciada por el tratamiento con Interleuquina 2 en pacientes bajo TARGA efectivo, pero con escasa ganancia de linfocitos... | |||||||||||||
Medical condition: Infección crónica por VIH | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000515-14 | Sponsor Protocol Number: GESIDA8014 | Start Date*: 2014-06-26 | |||||||||||
Sponsor Name:Fundación SEIMC-GESIDA | |||||||||||||
Full Title: Comparative, randomized, open study to evaluate maintenance with Darunavir/ritonavir once daily plus Lamivudine once daily versus continuing Darunavir/ritonavir once-daily plus Tenofovir/Emtricitab... | |||||||||||||
Medical condition: HIV chronic infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004350-91 | Sponsor Protocol Number: TAK-375/EC301 | Start Date*: 2005-11-10 | |||||||||||
Sponsor Name:Takeda Europe R&D Centre Ltd | |||||||||||||
Full Title: A multicentre, randomised, double-blind, double-dummy, placebo-controlled study to evaluate the safety and efficacy of ramelteon compared to placebo with zopiclone as a reference arm in adults with... | |||||||||||||
Medical condition: chronic insomnia | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) AT (Completed) FI (Completed) IT (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-001506-16 | Sponsor Protocol Number: IB 2005-33 | Start Date*: 2008-07-07 | |||||||||||
Sponsor Name:Institut Bergonié | |||||||||||||
Full Title: Diffuse large B cell non-hodgkin's lymphoma in the vulnerable/frail elderly. A multicentrix randomized phase II trial with emphasis on geritaric assesment and quality of life. | |||||||||||||
Medical condition: Vulnerable/Frail elderly patients older than 70 with diffuse large B-cell lymphoma stage II, III, or IV | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-003470-14 | Sponsor Protocol Number: FIMHCSVIH-2017 | Start Date*: 2018-12-12 | |||||||||||
Sponsor Name:FIMABIS Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
[...]
1. FIMABIS Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
2. APES Costa del Sol (Agencia Pública Empresarial Sanitaria Costa del Sol) |
|||||||||||||
Full Title: Pilot clinical trial, multicenter, to compare the efficacy of RTG 1200 QD vs DRV-cb (800-150) QD both in combination with TAF/FTC in patients with HIV and CD4 infection <200 cells/microL. | |||||||||||||
Medical condition: Human Immunodeficiency Virus (HIV) infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003544-30 | Sponsor Protocol Number: ACA-SPAI-05-06 | Start Date*: 2007-12-20 |
Sponsor Name:Dr. Ortega: Hospital General de Valencia | ||
Full Title: Estudio piloto, multicéntrico, aleatorizado y abierto, para evaluar el tratamiento concomitante de la co-infección por el VHC/VIH con peg-interferón + ribavirina, y lopinavir/r como único agente an... | ||
Medical condition: Varones y mujeres ≥ 18 años de edad con co-infección por el VIH y el VHC que no sufran enfermedad aguda, se encuentren recibiendo tratamiento antirretroviral y cuya viremia plasmática para el VIH (... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
